Literature DB >> 6329970

Expression of HLA-DR antigens in nasopharyngeal carcinoma: an immunohistological analysis of the tumour cells and infiltrating lymphocytes.

J A Thomas, V Iliescu, D H Crawford, R Ellouz, M Cammoun, G de-Thé.   

Abstract

A panel of conventional and monoclonal antibodies was used to examine the immunohistological characteristics of malignant epithelial cells and infiltrating lymphocytes in frozen sections of nasopharyngeal carcinoma (NPC) biopsies from 10 Tunisian patients. Three main categories of cells were identified. (1) Tumour cells which were positive for Epstein-Barr nuclear antigen, HLA-ABC and keratin determinants. In most samples, the tumour cells also expressed variable amounts of HLA-DR antigens. The presence of HLA-DR antigens has not been previously reported in NPC and may be a contributory factor in effecting the transfer of Epstein-Barr virus to the epithelial cells. (2) Infiltrating lymphocytes which were mainly composed of T inducer (T4+) and T suppressor/cytotoxic (T8+) cells although one sample contained predominantly immature T cells expressing the HTA-I+ cortical thymocyte phenotype. Few B cells or natural killer cells were demonstrated. (3) Large HTA-I+ dendritic cells which were invariably present within the tumour masses. These were morphologically and phenotypically similar to antigen presenting Langerhans cells which are usually located in the skin but also found in other epithelial sites. These cells may be a residual population from the normal nasopharynx or represent part of a specific immunological response to the presence of Epstein-Barr virus in the epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329970     DOI: 10.1002/ijc.2910330616

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  CD4+ T-cell responses to Epstein-Barr virus nuclear antigen EBNA1 in Chinese populations are highly focused on novel C-terminal domain-derived epitopes.

Authors:  C W Tsang; X Lin; N H Gudgeon; G S Taylor; H Jia; E P Hui; A T C Chan; C K Lin; A B Rickinson
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Immunohistological studies of lymphoproliferative lesions in a fatal case of Epstein-Barr virus infection.

Authors:  P Morgan-Capner; J A Morris; M B McIllmurray; J A Thomas; D H Crawford; T Azim
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

3.  Dendritic cell subpopulations in nasopharyngeal cancer.

Authors:  Johan S Nilsson; Milad Abolhalaj; Kristina Lundberg; Malin Lindstedt; Lennart Greiff
Journal:  Oncol Lett       Date:  2018-12-14       Impact factor: 2.967

4.  S-100 protein positive cells in nasopharyngeal carcinoma (NPC): absence of prognostic significance. A clinicopathological and immunohistochemical study of 40 cases.

Authors:  F J Vera-Sempere; C Micheau; A Llombart-Bosch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Immunohistological characteristics of the infiltrating lymphoid cells and expression of HLA class I and II antigens in nasopharyngeal carcinoma.

Authors:  F M Lai; P N Cheng; S Y Tsao; K N Lai
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Potential selection of LMP1 variants in nasopharyngeal carcinoma.

Authors:  Rachel H Edwards; Diane Sitki-Green; Dominic T Moore; Nancy Raab-Traub
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility.

Authors:  Xiu Chan Guo; Kevin Scott; Yan Liu; Michael Dean; Victor David; George W Nelson; Randall C Johnson; Holli H Dilks; James Lautenberger; Bailey Kessing; Janice Martenson; Li Guan; Shan Sun; Hong Deng; Yuming Zheng; Guy de The; Jian Liao; Yi Zeng; Stephen J O'Brien; Cheryl A Winkler
Journal:  Hum Genomics       Date:  2006-06       Impact factor: 4.639

8.  Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells.

Authors:  P Herait; G Ganem; M Lipinski; C Carlu; C Micheau; G Schwaab; G De-The; T Tursz
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

9.  Immune Phenotypes of Nasopharyngeal Cancer.

Authors:  Johan S Nilsson; Aastha Sobti; Sabine Swoboda; Jonas S Erjefält; Ola Forslund; Malin Lindstedt; Lennart Greiff
Journal:  Cancers (Basel)       Date:  2020-11-18       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.